These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 23351056

  • 1. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB.
    Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
    [Abstract] [Full Text] [Related]

  • 2. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.
    Circ Res; 2007 Feb 16; 100(3):342-53. PubMed ID: 17307972
    [Abstract] [Full Text] [Related]

  • 3. Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature.
    Hansen PB, Poulsen CB, Walter S, Marcussen N, Cribbs LL, Skøtt O, Jensen BL.
    Hypertension; 2011 Sep 16; 58(3):464-70. PubMed ID: 21788606
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.
    Thuesen AD, Andersen H, Cardel M, Toft A, Walter S, Marcussen N, Jensen BL, Bie P, Hansen PB.
    Am J Physiol Renal Physiol; 2014 Aug 15; 307(4):F445-52. PubMed ID: 24966091
    [Abstract] [Full Text] [Related]

  • 6. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
    Feng MG, Li M, Navar LG.
    Am J Physiol Renal Physiol; 2004 Feb 15; 286(2):F331-7. PubMed ID: 14583435
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles.
    Feng MG, Navar LG.
    Am J Physiol Renal Physiol; 2006 Apr 15; 290(4):F873-9. PubMed ID: 16263803
    [Abstract] [Full Text] [Related]

  • 8. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
    Poulsen CB, Al-Mashhadi RH, Cribbs LL, Skøtt O, Hansen PB.
    Kidney Int; 2011 Feb 15; 79(4):443-51. PubMed ID: 21068717
    [Abstract] [Full Text] [Related]

  • 9. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):424-34. PubMed ID: 18331727
    [Abstract] [Full Text] [Related]

  • 10. New Role of P/Q-type Voltage-gated Calcium Channels: From Transmitter Release to Contraction of Renal Vasculature.
    Hansen PB.
    J Cardiovasc Pharmacol; 2015 May 28; 65(5):406-11. PubMed ID: 25469806
    [Abstract] [Full Text] [Related]

  • 11. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C, Qiu C, Engels K.
    Am J Kidney Dis; 2001 Dec 28; 38(6):1292-7. PubMed ID: 11728963
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels.
    Hansen PB, Jensen BL, Andreasen D, Skøtt O.
    Circ Res; 2001 Sep 28; 89(7):630-8. PubMed ID: 11577029
    [Abstract] [Full Text] [Related]

  • 13. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K.
    Nihon Rinsho; 2004 Mar 28; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract] [Full Text] [Related]

  • 14. [Molecular effects of new calcium antagonists: is the principle of parcimony out of place?].
    Richard S, Virsolvy A, Fort A.
    Ann Cardiol Angeiol (Paris); 2008 Jun 28; 57(3):166-73. PubMed ID: 18565491
    [Abstract] [Full Text] [Related]

  • 15. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I, Tsien RW.
    Mol Pharmacol; 1995 Sep 28; 48(3):540-9. PubMed ID: 7565636
    [Abstract] [Full Text] [Related]

  • 16. [Pleiotropic effects of new generation calcium channel blockers on cardiovascular protections].
    Ogimoto A, Higaki J.
    Clin Calcium; 2013 Apr 28; 23(4):569-74. PubMed ID: 23545747
    [Abstract] [Full Text] [Related]

  • 17. Voltage-dependent calcium channels.
    Lacinová L.
    Gen Physiol Biophys; 2005 Jun 28; 24 Suppl 1():1-78. PubMed ID: 16096350
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
    Seino H, Miyaguchi S, Yamazaki T, Ota S, Yabe R, Suzuki S.
    Arzneimittelforschung; 2007 Jun 28; 57(8):526-31. PubMed ID: 17915639
    [Abstract] [Full Text] [Related]

  • 20. [New calcium channel blockers for the treatment of hypertension].
    Tamargo J.
    Hipertens Riesgo Vasc; 2017 Jun 28; 34 Suppl 2():5-8. PubMed ID: 29908667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.